VISTAGEN THERAPEUTICS, INC. Assets, Fair Value Disclosure
VISTAGEN THERAPEUTICS, INC. (VTGN) had Assets, Fair Value Disclosure of $31.73 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-14
- 2026-06-30: Assets, Fair Value Disclosure $31.73M.
- 2026-03-31: Assets, Fair Value Disclosure $45.40M.
- 2025-12-31: Assets, Fair Value Disclosure $61.77M.
- 2025-09-30: Assets, Fair Value Disclosure $77.17M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $31.73M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $45.40M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $61.77M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $77.17M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $63.18M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $80.48M 10-K · filed 2026-06-15 |
| 2024-12-31 | $88.56M 10-Q · filed 2025-02-13 |
| 2024-03-31 | $119.17M 10-K · filed 2025-06-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |